
Bioorganic and Medicinal Chemistry Letters p. 2773 - 2778 (1999)
Update date:2022-08-02
Topics:
Chambers
Marfat
Antognoli
Cheng
Damon
Kuperman
Liston
Mebus
Pillar
Shirley
Watson
CP-199,330 (3) and CP-199,331 (4) are cysLT1 receptor antagonists that are equipotent to marketed cysLT1 receptor antagonists zafirlukast and pranlukast, show good pharmacokinetics in rats and monkeys, and are devoid of liver toxicity in monkeys as seen in CP-85,958 (1).
View MoreLiaoyang Xinyou Chemical Products Co.,Ltd.
Contact:+86-419-5165433 13604191870
Address:Huishang Road6-1, Hongwei District, Liaoyang, Liaoning, China
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Nanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Contact:86-21-58226973
Address:No 351,Guoshoujing Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China
Contact:+8613400661290
Address:No 908,Kangwan Rd, Liuyang Economic
Doi:10.1039/jr9410000547
(1941)Doi:10.1002/jlcr.3073
(2013)Doi:10.1039/c3tc32388a
(2014)Doi:10.1016/j.tetlet.2014.02.024
(2014)Doi:10.1134/S1070363214020170
()Doi:10.1002/cctc.201300640
(2014)